tiprankstipranks
Trending News
More News >

Hemostemix Secures $1.8M in Private Placement

Story Highlights
Hemostemix Secures $1.8M in Private Placement

Hemostemix (TSE:HEM) has released an update.

Confident Investing Starts Here:

Hemostemix has successfully closed the first tranche of its private placement, raising approximately $1.8 million to boost its stem cell therapeutics platform and other operational needs. The funding will support initiatives like the initial sales and processing of angiogenic cell precursors (ACP). Additionally, Hemostemix granted stock options to its directors and officers, furthering its strategic business goals.

For further insights into TSE:HEM stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App